VARIABLE PARTICIPATION OF 5-HT1-LIKE RECEPTORS AND 5-HT2 RECEPTORS IN SEROTONIN-INDUCED CONTRACTION OF HUMAN - ISOLATED CORONARY-ARTERIES 5-HT1-LIKE RECEPTORS RESEMBLE CLONED 5-HT1D-BETA RECEPTORS

被引:171
作者
KAUMANN, AJ
FRENKEN, M
POSIVAL, H
BROWN, AM
机构
[1] AFRC, BABRAHAM INST, HUMAN PHARMACOL LAB, CAMBRIDGE, ENGLAND
[2] UNIV DUSSELDORF, INST EXP CHIRURG, W-4000 DUSSELDORF, GERMANY
[3] SMITHKLINE BEECHAM PHARMACEUT, HARLOW, ESSEX, ENGLAND
[4] HERZZENTRUM NORDRHEIN WESTFALEN, BAD OEYNHAUSEN, GERMANY
关键词
SEROTONIN; SUMATRIPTAN; RECEPTORS; CORONARY ARTERIES; CONTRACTION;
D O I
10.1161/01.CIR.90.3.1141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Serotonin may contract human large coronary arteries through two 5-hydroxtryptamine (5-HT) receptors, 5-HT1-like and 5-HT2. These 5-HT1-like receptors resemble both cloned 5-HT1D receptor subtypes, 5-HT1D alpha and 5-HT1D beta. Although these subtypes have similar pharmacology, 5-HT1D beta receptors appear to have lower affinity for ketanserin than 5-HT1D alpha receptors. We assessed the relative participation of 5-HT1-like and 5-HT2 receptors and attempted to identify whether vasoconstrictor 5-HT1-like receptors are 5-HT1D alpha or 5-HT1D beta. Methods and Results Epicardial coronary arteries were dissected from the hearts of 29 patients (including 1 healthy donor) undergoing heart transplant operation. Endothelium-denuded strips were set up to contract at 37 degrees C. To assess the relative contributions of 5-HT1-like and 5-HT2 receptors, we blocked the latter with ketanserin (0.1 to 1.0 mu mol/L) and ketanserin-resistant receptors with methiothepin (0.1 mu mol/L L). Concentration-effect curves for 5-HT, in the absence and presence of ketanserin, were analyzed by using a model for two receptor subtypes. The fractional contributions of 5-HT1-like and 5-HT2 receptors to the maximum effect of 5-HT, f(1) and f(2) were estimated in arteries from 28 patients: f(1), (0.71+/-0.20, mean+/-SD) was significantly larger than f(2) (0.29+/-0.20) (P<.0001). Using [H-3]-serotonin to label transfected and expressed receptors, we verified that ketanserin has lower affinity for 5-HT1D beta (pK(i) [-log K-i, mol/L] less than 5.0) than for 5-HT1D alpha (pK(i)=7.1+/-0.1) receptors. A concentration of ketanserin (1 mu mol/L) that would occupy more than 90% of 5-HT1D alpha receptors failed to block 5-HT-induced contractions (4 patients). The 5-HT1-like receptor stimulant sumatriptan evoked maximal contractions that matched f(1) and was equipotent with 5-HT through 5-HT1-like receptors (8 patients). No systematic influence of disease, atheroma, or therapy on f(1) and f(2) was detected. Conclusions Coronary artery contractile 5-HT1-like receptors resemble cloned 5-HT1D beta receptors and predominate over 5-HT2 receptors in mediating serotonin-evoked contractions. Sumatriptan contracts coronary arteries as a full agonist through 5-HT1-like receptors.
引用
收藏
页码:1141 / 1153
页数:13
相关论文
共 61 条
  • [1] CLONING OF ANOTHER HUMAN SEROTONIN RECEPTOR (5-HT1F) - A 5TH 5-HT1 RECEPTOR SUBTYPE COUPLED TO THE INHIBITION OF ADENYLATE-CYCLASE
    ADHAM, N
    KAO, HT
    SCHECHTER, LE
    BARD, J
    OLSEN, M
    URQUHART, D
    DURKIN, M
    HARTIG, PR
    WEINSHANK, RL
    BRANCHEK, TA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) : 408 - 412
  • [2] COOPERATIVE MEDIATION BY SEROTONIN-S2 AND THROMBOXANE-A2 PROSTAGLANDIN-H2 RECEPTOR ACTIVATION OF CYCLIC FLOW VARIATIONS IN DOGS WITH SEVERE CORONARY-ARTERY STENOSES
    ASHTON, JH
    OGLETREE, ML
    MICHEL, IM
    GOLINO, P
    MCNATT, JM
    TAYLOR, AL
    RAHEJA, S
    SCHMITZ, J
    BUJA, LM
    CAMPBELL, WB
    WILLERSON, JT
    [J]. CIRCULATION, 1987, 76 (04) : 952 - 959
  • [3] BARD JA, 1993, J BIOL CHEM, V268, P23422
  • [5] BODDEKE HWGM, 1992, N-S ARCH PHARMACOL, V345, P257
  • [6] PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE
    BRADLEY, PB
    ENGEL, G
    FENIUK, W
    FOZARD, JR
    HUMPHREY, PPA
    MIDDLEMISS, DN
    MYLECHARANE, EJ
    RICHARDSON, BP
    SAXENA, PR
    [J]. NEUROPHARMACOLOGY, 1986, 25 (06) : 563 - 576
  • [7] BRANCHEK T, 1990, MOL PHARMACOL, V38, P604
  • [8] 5-HYDROXYTRYPTAMINE RECEPTOR PROFILE IN HEALTHY AND DISEASED HUMAN EPICARDIAL CORONARY-ARTERIES
    CHESTER, AH
    MARTIN, GR
    BODELSSON, M
    ARNEKLONOBIN, B
    TADJKARIMI, S
    TORNEBRANDT, K
    YACOUB, MH
    [J]. CARDIOVASCULAR RESEARCH, 1990, 24 (11) : 932 - 937
  • [9] INTERACTION BETWEEN THROMBOXANE-A2 AND 5-HYDROXYTRYPTAMINE RECEPTOR SUBTYPES IN HUMAN CORONARY-ARTERIES
    CHESTER, AH
    ALLEN, SP
    TADJKARIMI, S
    YACOUB, MH
    [J]. CIRCULATION, 1993, 87 (03) : 874 - 880
  • [10] COMPARISON OF CONTRACTILE RESPONSES TO 5-HYDROXYTRYPTAMINE AND SUMATRIPTAN IN HUMAN ISOLATED CORONARY-ARTERY - SYNERGY WITH THE THROMBOXANE A(2)-RECEPTOR AGONIST, U46619
    COCKS, TM
    KEMP, BK
    PRUNEAU, D
    ANGUS, JA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (01) : 360 - 368